OBJECTIVES This study sought to determine if coronary artery calcium (CAC) is associated with incident noncardiovascular disease.
O ver the last 4 decades, there has been a substantial decline in cardiovascular disease (CVD) mortality, partly from improved identification and modification of risk factors (1) . The rate of non-CVD deaths has not declined as rapidly (2) , resulting in CVD decreasing to the second leading cause of death in certain populations (3) .
Coronary artery calcium (CAC) scoring is a noninvasive, direct measure of coronary atherosclerosis and powerful predictor of incident CVD and all-cause mortality (4) . CAC scores increase with chronologic age (5) .
However, there is considerable heterogeneity within age groups (6) translating into an "equivalent" chronologic age varying up to 30 years (7) . This potentially permits CAC scores to reclassify risk independent of age (8) . Indeed, CAC retains a strong predictive value for all-cause mortality beyond age (9) , raising the idea that CAC scores may provide a superior estimate of "arterial age" (10) .
CAC scores have been associated with the presence of traditional risk factors and likely partially represent the cumulative burden of risk factor exposure.
However, even those with no traditional CV risk factors can have elevated CAC scores and increased risk of CVD (11) . Higher levels of CAC are also associated with an increased risk of death from non-CVD causes (12) . This may be from higher incidences of other agerelated diseases, such as cancer, which has been associated with very high CAC scores (13). There have been mixed results when examining the relationship between CAC and other non-CVDs, such as kidney disease (14, 15) and decreased bone density (16, 17) .
To our knowledge, there have been no studies examining the relationship between CAC and other age-related diseases associated with significant morbidity and mortality, such as osteoporotic fractures, pneumonia, dementia, deep vein thrombosis (DVT), or pulmonary embolism (PE). We sought to evaluate whether CAC, as a marker of arterial age, is an independent predictor of non-CVD diagnoses. We hypothesized that having CAC ¼ 0 would be associated with a low risk of disease and having elevated CAC would be associated with a higher burden of non-CVD. CAC SCORE MEASUREMENTS. Detailed methods for computed tomography scan technique and interpretation were previously described (19) . Chicago, Los Angeles, and New York used cardiac-gated electronbeam computed tomography scanning. The other sites used multidetector computed tomography scanning. At the baseline examination, each participant was scanned 2 consecutive times with mean Agatston score used for the analysis. All images were interpreted at a single center, with good intrareader and inter-reader agreement (kappa ¼ 0.92). Coronary Calcium and Non-CV Disease -2 0 1 6 : --- Table 4 ).
METHODS
PNEUMONIA. There were 315 cases of pneumonia. Proportions ranged from 2.8% when CAC ¼ 0 to 10.6% in those with CAC >400 (p < 0.001) ( Figure 1) .
In multivariable-adjusted models (Model 5), there Coronary Calcium and Non-CV Disease -2 0 1 6 : --was a 7% increased hazard of being diagnosed with pneumonia with doubling of the CAC score (HR:
1.07; 95% CI: 1.03 to 1.11) ( Table 2) . Those with CAC >400 had 2 times the hazard of developing pneumonia compared with those with CAC ¼ 0 (HR: 1.97;
95% CI: 1.37 to 2.82) ( Table 3) . Those with CAC ¼ 0 did not have a significantly decreased risk of pneumonia (HR: 0.77; 95% CI: 0.58 to 1.01) when compared with those with CAC >0 ( Table 4 ). This was associated in unadjusted models but lost after controlling for demographic and lifestyle factors (Model 3, Table 4 ).
DVT OR PE. DVT or PE was documented in 205 participants. Among those with CAC ¼ 0, 1.1% were diagnosed, 1.9% in those with CAC ¼ 1 to 400 and 2.1% in those with CAC >400 (p < 0.05) (Figure 1) . In unadjusted models, doubling of CAC score and CAC >400 were associated with increased hazard of DVT Abbreviations as in Tables 1 and 2 . During follow-up, 161 participants were diagnosed with COPD. Proportions increased with increasing CAC score stratum from 1.2% in those with CAC ¼ 0 to 5.6% in those with CAC >400 (p < 0.001) ( Figure 1) . In Model 5, doubling of CAC score was associated with a 10% increased hazard of COPD (HR: 1.10; 95% CI: 1.05 to 1.16) ( Table 2) . Those with CAC >400 were 2.7 times more likely than those with CAC ¼ 0 (HR: 2.71; 95% CI:
1.60 to 4.57) to have a new diagnosis of COPD ( Table 3) . Those with CAC ¼ 0 were approximately half as likely to be diagnosed compared with those with any CAC (HR: 0.61; 95% CI: 0.40 to 0.91) ( Table 4 ).
DEMENTIA. Dementia was diagnosed in 119 participants and had increasing proportions with higher CAC stratum from 0.61% to 4.43% (p < 0.001) ( Figure 1) . After multivariable adjustment, doubling of the CAC score was associated with a 6% increased risk (HR: 1.06; 95% CI: 1.01 to 1.12) ( Table 2) .
Comparing those with CAC >400 with those with CAC ¼ 0, unadjusted models showed an increased HR of 6.45 (95% CI: 4.14 to 10.05) ( Table 3 ). This relationship was lost when controlling for age, sex, race, SES, and health insurance status (Model 2, Table 3) .
Similarly, those with CAC ¼ 0 compared with those with CAC >0 had a significant association in unadjusted models (HR: 0.26; 95% CI: 0.18 to 0.38) but this was lost when controlling for age, sex, race, SES, and health insurance status (Model 2, Table 4 ).
HIP FRACTURES. Hip fractures were the least common with 59 cases. Proportions diagnosed by CAC category ranged from 0.26% when CAC ¼ 0 to 1.77% in those with CAC >400 (p < 0.001) (Figure 1) . In multivariable adjusted models, doubling of CAC was associated with a 10% increased risk of events (1.01 to 1.21) ( Table 4 ).
AGGREGATE OUTCOME OF FIRST ANY NON-CVD
DIAGNOSIS. There were 1,238 first non-CVD diagnoses. The proportion of the first occurrence of any one of these was 11.0% for CAC ¼ 0, 22.5% for CAC ¼ 1 to 400, and 36.9% for CAC >400 (p < 0.001) ( Figure 2) . In multivariable adjusted models, doubling of the CAC score was associated with a 6% increased risk of any non-CVD diagnosis (HR: 1.06; 95% CI: 1.04 to 1.08) ( Table 2) . Those with CAC score >400 were 1.80 times more likely to be diagnosed with any non-CVD compared with those with CAC ¼ 0 (HR: 1.80; 95% CI: 1.48 to 2.18) ( Table 2 ). Coronary Calcium and Non-CV Disease -2 0 1 6 : ---AGE STRATIFICATION. Results of age stratified analysis are presented in Strengths of our analysis include the large sample, multiethnic makeup, detailed baseline risk factor assessment, and the use of a competing risk model, which is important given the known association of CAC with fatal CHD. In addition, rather than assuming a linear association, we allowed flexible modeling of age to achieve the best fit and thus limit residual confounding from age.
It is important to consider the possible mechanisms underlying these results. CAC per se is unlikely to be causally associated with non-CVD. In general, CAC is considered to be a risk integrator, and may reflect lifetime exposure to both measured and unmeasured risk factors shared in common between CVD and non-CVD outcomes (21) . It may also represent a common underlying vulnerability to the development of tissue injury at sites with varying relationships to the cardiovascular system. As such, the CAC score may be one marker of an individual's risk of future disease burden.
Pneumonia was not associated with CAC scores in models removing individuals with an interim nonfatal CHD event, suggesting it may be a more acute event that is more likely to be an incidental codiagnosis during the inpatient care for, or related to complications of, a CHD event. Furthermore, DVT/PE were weakly associated with CAC and are well known to have a variety of more acute-onset risk factors, including trauma and surgery (22) , which could be less related to CVD and arterial aging. Dementia likely had too few cases to confirm an association with CAC given the large CI.
IMPLICATIONS. We hypothesized that CAC scores could be a surrogate measure of arterial aging and identify those at increased risk of age-related, non-CV disease. CAC has been described as a measure of so-called "biologic age" (7) , supported by studies showing absolute CAC scores as better predictors of CVD events than age alone (10) . Our results support CAC as a marker for other age-related diseases and support limited prior findings showing an association between elevated CAC scores and non-CV diseases including cancer (13) and COPD (23) . Although CAC has been shown to be associated with all-cause mortality (24) (25) (26) , this association may be driven by An important finding is that people with CAC ¼ 0 seem to be protected from CVD and other chronic diseases. These "healthy agers" are at very low risk of CVD and non-CVD morbidity and mortality (24, 27, 28) . There are broad implications to identifying and studying such people in the population. Statistically significant values are in bold. Nonsignificant values are in italics. Cox proportional hazards ratios (and 95% confidence intervals) for those <65 and those $65 years of age. Model is adjusted for age (best fit, see the Methods section), sex, race, health insurance status, socioeconomic status (completed high school and income level), body mass index, physical activity, diet, smoking status and pack-years, total number of medications used, systolic blood pressure, diastolic blood pressure, antihypertensive medications, total cholesterol, high-density lipoprotein cholesterol, lipid-lowering medications, diabetes, and aspirin use. The interaction of CAC with age < or $ 65 years was not significant. Tables 1 and 2 Coronary Calcium and Non-CV Disease -2 0 1 6 : ---
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